Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Other Operating Expenses: 2010-2023

Historic Other Operating Expenses for Altimmune (ALT) over the last 8 years, with Dec 2023 value amounting to $12.4 million.

  • Altimmune's Other Operating Expenses was N/A to $12.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $24.8 million, marking a year-over-year change of. This contributed to the annual value of $12.4 million for FY2023, which is N/A change from last year.
  • According to the latest figures from FY2023, Altimmune's Other Operating Expenses is $12.4 million, which was up 9.23% from $11.4 million recorded in FY2021.
  • In the past 5 years, Altimmune's Other Operating Expenses ranged from a high of $12.4 million in FY2023 and a low of $1.0 million during FY2019.
  • Its 2-year average for Other Operating Expenses is $11.9 million, with a median of $11.9 million in 2021.
  • Data for Altimmune's Other Operating Expenses shows a maximum YoY tumbled of 95.99% (in 2019) over the last 5 years.
  • Altimmune's Other Operating Expenses (Yearly) stood at $1.0 million in 2019, then followed by $11.4 million in 2021, then followed by $12.4 million in 2023.